{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:19:41Z","timestamp":1785464381772,"version":"3.56.0"},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,11,23]],"date-time":"2009-11-23T00:00:00Z","timestamp":1258934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Genetics"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:p>Selvanathan SK, Shenton A, Ferner R, Wallace AJ, Huson SM, Ramsden RT, Evans DG. Further genotype\u2013phenotype correlations in neurofibromatosis 2.<\/jats:p><jats:p>Neurofibromatosis 2 (NF2) is caused by mutations in the NF2 gene predisposing carriers to develop nervous system tumours. Different NF2 mutations result in either loss\/reduced protein function or gain of protein function (abnormally behaving mutant allele i.e. truncated protein potentially causing dominant negative effect). We present a comparison between the clinical presentations of patients with mutations that are predicted to produce truncated protein (nonsense\/frameshift mutations) to those that results in loss of protein expression (large deletions) to elucidate further genotype\u2013phenotype correlations in NF2. Patients with nonsense\/frameshift mutations have a younger age of diagnosis and a higher prevalence\/proportion of meningiomas (p = 0.002, p = 0.014), spinal tumours (p = 0.004, p = 0.004) and non\u2010VIII cranial nerve tumours (p = 0.006, p = 0.003). We also found younger age of diagnosis of vestibular schwannomas (p = 0.007), higher mean numbers of cutaneous lesions (p = 0.003) and spinal tumours (p = 0.006) in these patients. With respect to NF2 symptoms, we found younger age of onset of hearing loss (p = 0.010), tinnitus (p = 0.002), paraesthesiae (p = 0.073), wasting and weakness (p = 0.001) and headaches (p = 0.049) in patients with nonsense\/frameshift mutations. Our comparison shows, additional, new correlations between mutations in the NF2 gene and the NF2 disease phenotype, and this further confirms that nonsense\/frameshift mutations are associated with more severe NF2 symptoms. Therefore patients with this class of NF2 mutation should be followed up closely.<\/jats:p>","DOI":"10.1111\/j.1399-0004.2009.01315.x","type":"journal-article","created":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T02:56:45Z","timestamp":1259031405000},"page":"163-170","source":"Crossref","is-referenced-by-count":91,"title":["Further genotype \u2013 phenotype correlations in neurofibromatosis 2"],"prefix":"10.1111","volume":"77","author":[{"given":"SK","family":"Selvanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Shenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ferner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AJ","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SM","family":"Huson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RT","family":"Ramsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DG","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/363515a0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90406-G"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.29.12.841"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2002.96.2.0217"},{"issue":"2","key":"e_1_2_6_6_2","first-page":"331","article-title":"Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease","volume":"59","author":"Ruttledge MH","year":"1996","journal-title":"Am J Hum Genet"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2002.96.2.0223"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2003.99.3.0480"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.35.6.450"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20317"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/422700"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00208973"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.3.335"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870120206"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004390050255"},{"issue":"3","key":"e_1_2_6_16_2","first-page":"529","article-title":"Germ\u2010line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities","volume":"59","author":"Parry DM","year":"1996","journal-title":"Am J Hum Genet"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/302004"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.13.2051"},{"issue":"1","key":"e_1_2_6_19_2","first-page":"69","article-title":"A mutation in the neurofibromatosis type 2 tumor\u2010suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals","volume":"55","author":"Bourn D","year":"1994","journal-title":"Am J Hum Genet"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.047753"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320520411"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200302000-00004"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.10181"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.029504"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.165.4.7676998"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.218.2.r01fe40434"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.3171\/spi.2005.2.5.0574"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890480059008"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19960906)64:4<563::AID-AJMG7>3.0.CO;2-Q"}],"container-title":["Clinical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0004.2009.01315.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0004.2009.01315.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:36:29Z","timestamp":1698755789000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0004.2009.01315.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,11]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1399-0004.2009.01315.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0004.2009.01315.x","archive":["Portico"],"relation":{},"ISSN":["0009-9163","1399-0004"],"issn-type":[{"value":"0009-9163","type":"print"},{"value":"1399-0004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,11]]}}}